• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Processa Pharmaceuticals, Inc. - Common Stock (NQ:PCSA)

1.920 -0.020 (-1.03%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Processa Pharmaceuticals, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
February 03, 2023
Good morning! It's time to start the final day of trading this week with a look at the biggest pre-market stock movers for Friday! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
February 02, 2023
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
January 30, 2023
  On Monday, 13 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
January 25, 2023
  On Wednesday, 22 companies hit new 52-week lows. 
Via Benzinga
News headline image
Processa Pharma's Investigational Candidate Improves Gastroparesis-Associated Clinical Symptoms ↗
December 14, 2022
 
Via Benzinga
News headline image
Earnings Scheduled For August 11, 2022 ↗
August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. 
Via Benzinga
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at Biotech Showcase
January 04, 2023
Via Investor Brand Network
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
December 30, 2022
  Friday's session saw 75 companies set new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
December 21, 2022
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
December 21, 2022
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
December 29, 2022
  On Thursday, 116 companies set new 52-week lows. 
Via Benzinga
InvestorNewsBreaks – Processa Pharmaceuticals Inc.’s (NASDAQ: PCSA) PCS12852 Demonstrates Clinically Meaningful Improvements in Gastroparesis Symptoms
December 14, 2022
Via Investor Brand Network
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
December 22, 2022
  Thursday's session saw 329 companies set new 52-week lows. 
Via Benzinga
News headline image
Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session ↗
December 14, 2022
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share. 
Via Benzinga
News headline image
Processa Pharmaceuticals Announces PCS12852 Successfully Improves the Clinical Symptoms Associated with Gastroparesis in Phase 2A Trial
December 14, 2022
From Processa Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update
November 08, 2022
From Processa Pharmaceuticals, Inc.
Via GlobeNewswire
InvestorNewsBreaks – Processa Pharmaceuticals Inc.’s (NASDAQ: PCSA) PCS12852 Demonstrates Improved Gastric Emptying in Phase 2A Trial
November 08, 2022
Via Investor Brand Network
News headline image
PCS12852 Improves Gastric Emptying in Gastroparesis Patients
November 08, 2022
From Processa Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Earnings Preview: Processa Pharmaceuticals ↗
November 07, 2022
Processa Pharmaceuticals (NASDAQ:PCSA) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Host Conference Call to Discuss Q3 2022 Results, Provide Pipeline Update
November 02, 2022
Via Investor Brand Network
News headline image
Processa Pharmaceuticals to Host Conference Call to Discuss Third Quarter 2022 Results and Provide Drug Development Update on November 8, 2022 at 4:30 p.m. EST
November 02, 2022
From Processa Pharmaceuticals, Inc.
Via GlobeNewswire
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Reports Successful Results from NGC Phase 2B Trial
November 01, 2022
Via Investor Brand Network
News headline image
Processa Successfully Identifies Next Generation Capecitabine Dosage Regimens for Phase 2B Trial
November 01, 2022
From Processa Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday ↗
September 29, 2022
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial... 
Via Benzinga
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Shares Update on Clinical Programs Enrollment
September 15, 2022
Via Investor Brand Network
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Participate at Upcoming Global Investment Conference
September 07, 2022
Via Investor Brand Network
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Names New Key Board Appointments
August 16, 2022
Via Investor Brand Network
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Releases Q2 2022 Results, Corporate Updates
August 12, 2022
Via Investor Brand Network
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Q2 2022 Results Conference Call
August 08, 2022
Via Investor Brand Network
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Launches New Website Focused on Rare Disease
August 04, 2022
Via Investor Brand Network
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap